These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 8369235)
1. Cognitive functioning and anhedonia in subjects at risk for schizophrenia. Franke P; Maier W; Hardt J; Hain C Schizophr Res; 1993 Jun; 10(1):77-84. PubMed ID: 8369235 [TBL] [Abstract][Full Text] [Related]
2. Executive/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives. Laurent A; Biloa-Tang M; Bougerol T; Duly D; Anchisi AM; Bosson JL; Pellat J; d'Amato T; Dalery J Schizophr Res; 2000 Dec; 46(2-3):269-83. PubMed ID: 11120438 [TBL] [Abstract][Full Text] [Related]
3. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Cannon TD; Zorrilla LE; Shtasel D; Gur RE; Gur RC; Marco EJ; Moberg P; Price RA Arch Gen Psychiatry; 1994 Aug; 51(8):651-61. PubMed ID: 8042914 [TBL] [Abstract][Full Text] [Related]
13. Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder. Trestman RL; Keefe RS; Mitropoulou V; Harvey PD; deVegvar ML; Lees-Roitman S; Davidson M; Aronson A; Silverman J; Siever LJ Psychiatry Res; 1995 Nov; 59(1-2):127-36. PubMed ID: 8771227 [TBL] [Abstract][Full Text] [Related]
14. Cognitive correlates of schizophrenia signs and symptoms: II. Emotional disturbances. Berenbaum H; Kerns JG; Vernon LL; Gomez JJ Psychiatry Res; 2008 May; 159(1-2):157-62. PubMed ID: 18423613 [TBL] [Abstract][Full Text] [Related]
15. WCST performance and schizotypal features in the first-degree relatives of patients with schizophrenia. Laurent A; Duly D; Murry P; Foussard N; Boccara S; Mingat F; Dalery J; d'Amato T Psychiatry Res; 2001 Nov; 104(2):133-44. PubMed ID: 11711167 [TBL] [Abstract][Full Text] [Related]
16. Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia. Purdon SE; Valiakalayil A; Hanstock CC; Seres P; Tibbo P Schizophr Res; 2008 Feb; 99(1-3):218-24. PubMed ID: 18248960 [TBL] [Abstract][Full Text] [Related]
17. The New York High-Risk Project: anhedonia, attentional deviance, and psychopathology. Erlenmeyer-Kimling L; Cornblatt BA; Rock D; Roberts S; Bell M; West A Schizophr Bull; 1993; 19(1):141-53. PubMed ID: 8451608 [TBL] [Abstract][Full Text] [Related]
18. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
19. Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives. Laurent A; Saoud M; Bougerol T; d'Amato T; Anchisi AM; Biloa-Tang M; Dalery J; Rochet T Psychiatry Res; 1999 Dec; 89(3):147-59. PubMed ID: 10708262 [TBL] [Abstract][Full Text] [Related]
20. Attentional abilities and measures of schizotypy: their variation and covariation in schizophrenic patients, their siblings, and normal control subjects. Franke P; Maier W; Hardt J; Hain C; Cornblatt BA Psychiatry Res; 1994 Dec; 54(3):259-72. PubMed ID: 7792330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]